Why Is Caris Life Sciences Stock Gaining Wednesday?

Benzinga_recent_news04-01

The Achieve 1 Study results released on Tuesday indicate a significant milestone for Caris Detect, the company’s multi-cancer early detection test, which aims to identify various cancer types at early...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624514930?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/01/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-04-01 22:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624514930","market":"hk","top_or_hot":-1,"title":"Why Is Caris Life Sciences Stock Gaining Wednesday?","media":"Benzinga_recent_news","content":"<div>\n<p>The Achieve 1 Study results released on Tuesday indicate a significant milestone for Caris Detect, the company’s multi-cancer early detection test, which aims to identify various cancer types at early...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/04/51599751/why-is-caris-life-sciences-stock-gaining-wednesday\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Caris Life Sciences Stock Gaining Wednesday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Caris Life Sciences Stock Gaining Wednesday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-01 22:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/04/51599751/why-is-caris-life-sciences-stock-gaining-wednesday><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Achieve 1 Study results released on Tuesday indicate a significant milestone for Caris Detect, the company’s multi-cancer early detection test, which aims to identify various cancer types at early...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/04/51599751/why-is-caris-life-sciences-stock-gaining-wednesday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/04/51599751/why-is-caris-life-sciences-stock-gaining-wednesday","article_id":"2624514930","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/01/cancer.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51599751/why-is-caris-life-sciences-stock-gaining-wednesday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2624514930","pubTimestamp":1775052180,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Caris Life Sciences stock surges on positive Achieve 1 cancer test data. See key CAI levels and study results here.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","CAI":"Caris Life Sciences, Inc.","BK4217":"自存仓储房地产信托","BK4104":"贸易公司与经销商","SMA":"Smartstop Self Storage REIT Inc"},"translate_title":"为什么Caris Life Sciences股票周三上涨？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMA":1,"CAI":1.5},"content_text":"The Achieve 1 Study results released on Tuesday indicate a significant milestone for Caris Detect, the company’s multi-cancer early detection test, which aims to identify various cancer types at early stages through blood sampling.\nA total of 3,014 subjects were enrolled in the study, showcasing the test’s efficacy in a high-risk population, which is crucial for early cancer detection.\nAdditionally, the study’s findings highlight that the Whole Genome Sequencing approach can detect diverse molecular changes that drive cancer.\nThis advancement is expected to enhance the overall performance of Caris Detect as the company plans to incorporate additional pillars, including Whole Transcriptome Sequencing.\nThe company shared the interim readout from Achieve 1 in February.\nThe data highlighted Caris Detect’s superiority in sensitivity and specificity compared to traditional methods, with the study involving approximately 1,505 samples from undiagnosed patients.\nIn addition, Caris processed over one million cases, generating more than 50 billion molecular markers, which underscores its robust data foundation for AI-driven cancer detection.\nCaris Life Sciences reported fourth-quarter earnings of 28 cents compared to the consensus loss of 3 cents.\nSales for the quarter jumped 125% year over year to $292.89 million, beating the consensus of $208.63 million.\nThe increase was driven primarily by a 199% growth in molecular profiling services revenue, which was $282.1 million, attributable to an increase in total clinical case volume and ASP improvements across therapy selection solutions.\nThe company completed approximately 52,700 clinical therapy selection cases, an increase of approximately 20% year over year, consisting of approximately 44,150 MI Profile cases and approximately 8,550 Caris Assure cases.\nCaris Life Sciences expects fiscal 2026 sales between $1 and $1.02 billion versus the consensus of $1.198 billion.\nThe stock is currently trading 1.84% below its 20-day simple moving average (SMA) and 12.09% below its 100-day SMA, indicating a bearish short-term trend.\nShares have decreased 36.14% over the past 12 months and are currently positioned closer to their 52-week lows than highs.\nThe RSI is at 41.87, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD is at -0.7990, with a signal line at -0.8267, indicating a bullish signal as the MACD is above the signal line.\nThe combination of neutral RSI and bullish MACD suggests mixed momentum, indicating that while the stock is not in an oversold condition, there may be potential for upward movement.\nCAI Price Action: Caris Life Sciences shares were up 6.49% at $19.04 at the time of publication on Wednesday, according to Benzinga Pro data.\nPhoto by Aunt Spray via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624514930","isCrawlerRequest":true}